AIDS

1. SULLIVAN EV, Zahr NM, Zhao Q, Pohl KM, et al
   Contributions of cerebral white matter hyperintensities, age, and pedal perception to postural sway in people living with HIV.
   AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003894.
   

   >> Share

   
   
2. SCHNURE MC, Kasaie P, Dowdy DW, Genberg BL, et al
   Forecasting the effect of HIV-targeted interventions on the age distribution of people living with HIV: a case study from Kenya.
   AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003895.
   

   >> Share

   
   
3. GIANELLA S, Anderson C, Chaillon A, Wells A, et al
   Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy.
   AIDS. 2024 Mar 25. doi: 10.1097/QAD.0000000000003882.
   

   >> Share

   
   
4. WIJSTMA ES, Jongen VW, Boyd A, van den Elshout M, et al
   Concordance between daily diary reported PrEP intake and intraerythrocytic tenofovir diphosphate (TFV-DP) in the Amsterdam PrEP demonstration project.
   AIDS. 2024 Mar 21. doi: 10.1097/QAD.0000000000003889.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

5. RENRONG T, Li T, Zhang MX, Song TZ, et al
   Nonnegligible contribution of non-lymphoid tissue to viral reservoir during the short-term early cART in SIVmac239-infected Chinese rhesus macaques.
   AIDS Res Hum Retroviruses. 2024 Mar 27. doi: 10.1089/AID.2023.0130.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

6. COSSU MV, D'Avolio A, Gervasoni C, Giacomelli A, et al
   Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV.
   Antimicrob Agents Chemother. 2024 Mar 27:e0017524. doi: 10.1128/aac.00175.
   

   >> Share

   
   
7. HAN K
   Reply to Cossu et al., "Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV".
   Antimicrob Agents Chemother. 2024 Mar 27:e0020424. doi: 10.1128/aac.00204.
   

   >> Share

   
   

   
   Cancer

8. MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al
   Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
   Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289.
   

   >> Share

   
   

   
   Clin Infect Dis

9. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
   Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
   Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
   

   >> Share

   
   
10. JAO J, Bonner LB, Dobinda K, Powis KM, et al
    Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.
    Clin Infect Dis. 2024 Mar 26:ciae088. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

11. LIU Y, Cheng Z, Xian Y, Liu X, et al
    Cascade analysis of awareness, willingness, uptake and adherence with regard to PrEP among young men who have sex with men (YMSM) in China: A comparison between students and non-students.
    HIV Med. 2024 Mar 27. doi: 10.1111/hiv.13639.
    

    >> Share

    
    
12. OTTAWAY Z, Campbell L, Fox J, Burns F, et al
    HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in England.
    HIV Med. 2024 Mar 26. doi: 10.1111/hiv.13640.
    

    >> Share

    
    
13. SAWRY S, Ayalew K, Maimela G, Briggs-Hagen M, et al
    Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study.
    HIV Med. 2024 Mar 22. doi: 10.1111/hiv.13638.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

14. LINNEMAYR S, Wagner Z, Saya UY, Stecher C, et al
    Behavioral economic incentives to support HIV care: Results from a randomized controlled trial in Uganda.
    J Acquir Immune Defic Syndr. 2024 Mar 27. doi: 10.1097/QAI.0000000000003420.
    

    >> Share

    
    
15. QIAN Y, Zhang P, Wang L, Suo J, et al
    The association of intraocular efavirenz concentrations and HIV-1 viral load among persons with HIV.
    J Acquir Immune Defic Syndr. 2024 Mar 25. doi: 10.1097/QAI.0000000000003426.
    

    >> Share

    
    
16. PATEL D, Williams WO, Wright C, Essuon A, et al
    CDC-Funded HIV Testing and Undiagnosed HIV Infection in Ending the HIV Epidemic in the U.S. Jurisdictions.
    J Acquir Immune Defic Syndr. 2024 Mar 23. doi: 10.1097/QAI.0000000000003424.
    

    >> Share

    
    
17. HICKEY MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, et al
    Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed.
    J Acquir Immune Defic Syndr. 2024 Mar 27. doi: 10.1097/QAI.0000000000003421.
    

    >> Share

    
    

    
    J Infect Dis

18. OLSSON O, Sokilde R, Tesfaye F, Karlson S, et al
    Tuberculosis disease is associated with elevated plasma ribonuclease activity in antiretroviral treatment-naive people with HIV.
    J Infect Dis. 2024 Mar 25:jiae143. doi: 10.1093.
    

    >> Share

    
    
19. XIU F, Flores Anato JL, Cox J, Grace D, et al
    Characteristics of the Sexual Networks of Men Who Have Sex With Men in Montreal, Toronto, and Vancouver: Insights from Canada's 2022 Mpox Outbreak.
    J Infect Dis. 2024;229.
    

    >> Share

    
    
20. SNYDER RE, Saadeh K, Tang EC, Johnson KA, et al
    Sexual Exposures Associated With Mpox Infection: California, November 2022 to June 2023.
    J Infect Dis. 2024;229.
    

    >> Share

    
    

    
    J Med Virol

21. KASSAM P, El-Zein M, Laurie C, Tota JE, et al
    Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men.
    J Med Virol. 2024;96:e29562.
    

    >> Share

    
    
22. FARAONE JN, Wang X, Qu P, Zheng YM, et al
    Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination.
    J Med Virol. 2024;96:e29520.
    

    >> Share

    
    
23. KIM M, Kim E
    Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process.
    J Med Virol. 2024;96:e29558.
    

    >> Share

    
    

    
    JAMA

24. STOOPLER ET, Villa A, Bindakhil M, Diaz DLO, et al
    Common Oral Conditions: A Review.
    JAMA. 2024;331:1045-1054.
    

    >> Share

    
    

    
    Lancet

25. BEYRER C, Kamarulzaman A, Isbell M, Amon J, et al
    Under threat: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2024 Mar 20:S0140-6736(24)00302-7. doi: 10.1016/S0140-6736(24)00302.
    

    >> Share

    
    

    
    Lancet Infect Dis

26. 
    Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet Infect Dis. 2024 Mar 19:S1473-3099(24)00007.
    

    >> Share

    
    
27. LADHANI SN, White PJ, Campbell H, Mandal S, et al
    Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK.
    Lancet Infect Dis. 2024 Mar 20:S1473-3099(24)00031.
    

    >> Share

    
    
28. NAIDOO K, Perumal R, Cox H, Mathema B, et al
    The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis-lessons from the South African experience.
    Lancet Infect Dis. 2024 Mar 22:S1473-3099(24)00144.
    

    >> Share

    
    
29. CHAKAYA J, Fatma R, Cader M, Harries AD, et al
    Post-tuberculosis lung disease: is there a light at the end of tunnel?
    Lancet Infect Dis. 2024 Mar 22:S1473-3099(24)00136.
    

    >> Share

    
    

    
    Nat Med

30. O'LEARY K
    Combination treatment for immune-mediated HIV remission.
    Nat Med. 2024 Mar 26. doi: 10.1038/d41591-024-00020.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

31. GREYBE L, Barnabas S, Cotton M, Rose P, et al
    Cardiometabolic Risk Profiles of Adolescents Living With Perinatally Acquired HIV in South Africa.
    Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004340.
    

    >> Share

    
    

    
    PLoS One

32. SAKOI-MOSETLHI M, Ajibola G, Haghighat R, Batlang O, et al
    Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART.
    PLoS One. 2024;19:e0299942.
    

    >> Share

    
    
33. SINGATA-MADLIKI M, Smit J, Beksinska M, Balakrishna Y, et al
    Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
    PLoS One. 2024;19:e0295764.
    

    >> Share

    
    
34. 
    Expression of Concern: Evidence that Vpu Modulates HIV-1 Gag-Envelope Interaction towards Envelope Incorporation and Infectivity in a Cell Type Dependent Manner.
    PLoS One. 2024;19:e0301303.
    

    >> Share

    
    
35. AHMADPOUR E, Valilou S, Ghanizadegan MA, Seyfi R, et al
    Global prevalence, mortality, and main characteristics of HIV-associated pneumocystosis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297619.
    

    >> Share

    
    
36. OWUSU M, Adu E, Kalu LE, Martey E, et al
    Aetiological agents of pneumonia among HIV and non-HIV infected children in Ghana: A case-control study.
    PLoS One. 2024;19:e0299222.
    

    >> Share

    
    
37. AGIMAS MC, Solomon M, Shewaye DA, Abebaw Angaw D, et al
    Prevalence of delayed treatment for sexually transmitted infections and its determinants in sub-Saharan Africa. A systematic review and meta-analysis.
    PLoS One. 2024;19:e0299629.
    

    >> Share

    
    
38. VECHI HT, Bay MB, Freitas CHS, Sant'anna JGFC, et al
    Factors associated with hepatitis A susceptibility among men who have sex with men using HIV pre-exposure prophylaxis in Northeastern Brazil: A cross-sectional study.
    PLoS One. 2024;19:e0301397.
    

    >> Share

    
    

    
    Science

39. COHEN J
    Africa may lead rollout of long-lasting HIV drug.
    Science. 2024;383:1403.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share